Patients hospitalized with the omicron or delta variants of COVID-19 required similar levels of respiratory support and intensive care, according to a new Johns Hopkins study, indicating that omicron infections should not ...
Apr 25, 2022
0
34
Women who were pregnant during the recent Omicron surge were diagnosed with COVID-19 at a much higher rate than during previous phases of the pandemic, but were less likely to develop severe illness, a study by UT Southwestern ...
Apr 25, 2022
0
28
Most infants enrolled in the Special Supplemental Nutrition Program for Women, Infants, and Children, also known as WIC, are likely not getting the recommended daily amount of vitamin D, according to new research from the ...
Apr 19, 2022
0
7
Kids can be stubborn when it comes to eating the healthy foods on their plate.
Apr 18, 2022
0
44
Combining a retrospective analysis of clinical records with in-depth laboratory studies, researchers at The University of Texas MD Anderson Cancer Center have discovered that vitamin E can enhance immunotherapy responses ...
Apr 14, 2022
0
16
Could dietary supplements become a healthy weapon against COVID-19? Experts from TAU have shown that common dietary supplements can protect against the coronavirus as well as several common winter illnesses.
Apr 13, 2022
1
66
An experimental medication for critically ill COVID-19 patients appears to work so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization.
Apr 12, 2022
0
9
Zinc's immune-boosting properties are well-established, but we're still untangling how it works. In a new study published in late March in the scientific journal Blood, Fred Hutchinson Cancer Research Center scientists reveal ...
Mar 31, 2022
0
51
Ulcerative colitis (UC) is a nonspecific, chronic and recurrent inflammatory bowel disease. Alpinia plants (Zingiberaceae family) are the ideal materials for finding therapeutic agents against UC. Alpinia hainanensis is an ...
Mar 31, 2022
0
3
Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.
Mar 31, 2022
0
2
